share_log

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chambers Michael Andrew

SEC ·  Aug 20 20:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more